Timothy Henkel

1.8k total citations · 2 hit papers
10 papers, 1.4k citations indexed

About

Timothy Henkel is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Timothy Henkel has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Timothy Henkel's work include Antifungal resistance and susceptibility (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Respiratory and Cough-Related Research (2 papers). Timothy Henkel is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Respiratory and Cough-Related Research (2 papers). Timothy Henkel collaborates with scholars based in United States, United Kingdom and Canada. Timothy Henkel's co-authors include James B. Young, H. Jeffrey Wilkins, Mario Castro, Frederick E. Hargreave, Louis‐Philippe Boulet, Parameswaran Nair, Sameer K. Mathur, Fang Xie, James A. Dowell and Marc E. Rothenberg and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Timothy Henkel

10 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study

2011 547 citations Mario Castro, Sameer K. Mathur et al. American Journal of Respiratory and Critical Care Medicine profile →
Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial

2011 400 citations Jonathan M. Spergel, Marc E. Rothenberg et al. Journal of Allergy and Clinical Immunology profile →

Peers

Timothy Henkel

PHYSI

SURGE

PRM

RHEUM

ID

Giovanna Zanoni Italy

Robert C. Radin United States

Karl Baumgart Australia

Enrico Iemoli Italy

Pekka Saikku Finland

Rannakoe Lehloenya South Africa

Manish Patel United States

V. Faber Denmark

Masaharu Shinkai Japan

P Quandallé France

Giovanna Zanoni Italy

Timothy Henkel

115 ×0.2

PHYSI

112 ×0.2

SURGE

92 ×0.3

PRM

145 ×0.4

RHEUM

164 ×0.5

ID

Citations per year, relative to Timothy Henkel Timothy Henkel (= 1×) peers Giovanna Zanoni

Countries citing papers authored by Timothy Henkel

Since Specialization

Citations

This map shows the geographic impact of Timothy Henkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Henkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Henkel more than expected).

Fields of papers citing papers by Timothy Henkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Henkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Henkel. The network helps show where Timothy Henkel may publish in the future.

Co-authorship network of co-authors of Timothy Henkel

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Henkel. A scholar is included among the top collaborators of Timothy Henkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Henkel. Timothy Henkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Dowell, James A., et al.. (2018). 1401. A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single and Repeat Doses of VNRX-5133 in Healthy Subjects. Open Forum Infectious Diseases. 5(suppl_1). S431–S431. 9 indexed citations

2.

Castro, Mario, Sameer K. Mathur, Frederick E. Hargreave, et al.. (2011). Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study. American Journal of Respiratory and Critical Care Medicine. 184(10). 1125–1132. 547 indexed citations breakdown →

3.

Spergel, Jonathan M., Marc E. Rothenberg, Margaret H. Collins, et al.. (2011). Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 129(2). 456–463.e3. 400 indexed citations breakdown →

4.

Dowell, James A., Martin Stogniew, David Krause, Timothy Henkel, & Bharat Damle. (2007). Lack of Pharmacokinetic Interaction Between Anidulafungin and Tacrolimus. The Journal of Clinical Pharmacology. 47(3). 305–314. 49 indexed citations

5.

Dörr, Marcus, Daniela Jabés, James A. Dowell, et al.. (2005). Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide. Journal of Antimicrobial Chemotherapy. 55(suppl_2). ii25–ii30. 86 indexed citations

6.

Dowell, James A., et al.. (2005). Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine. The Journal of Clinical Pharmacology. 45(2). 227–233. 82 indexed citations

7.

Krause, David S., John F. Reinhardt, José A. Vázquez, et al.. (2004). Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia. Antimicrobial Agents and Chemotherapy. 48(6). 2021–2024. 129 indexed citations

8.

Ball, Peter, Thomas M. File, Monique Twynholm, & Timothy Henkel. (2001). Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections. International Journal of Antimicrobial Agents. 18(1). 19–27. 23 indexed citations

9.

Ebenbichler, Christoph, Peter Westervelt, Alejandro Vicente‐Carrillo, et al.. (1993). Structure—function relationships of the HIV-1 envelope V3 loop tropism determinant. AIDS. 7(5). 639–646. 35 indexed citations

10.

Nair, Muraleedharan G., et al.. (1981). Folate analogs altered in the C9-N10 bridge region. 18. Synthesis and antitumor evaluation of 11-oxahomoaminopterin and related compounds. Journal of Medicinal Chemistry. 24(9). 1068–1073. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact